Now Available: ARMLUPEG® with Established Medicare Payment Limit

Now Available October 1, 2026

ARMLUPEG^®

(pegfilgrastim-unne) injection, ready to order and ready to bill.

Permanent HCPCS Code

Q5169

Medicare Payment Limit

$519.481

Per unit, effective Oct 1, 2026

Valorum Biologics' ARMLUPEG^® (pegfilgrastim-unne), a biosimilar to Neulasta^® (pegfilgrastim), is available to order from your wholesaler or distributor beginning October 1, 2026.

The Medicare Part B payment limit for Q5169 is effective October 1, 2026. ARMLUPEG is available to order with both a permanent HCPCS code and an established Medicare payment limit in place. Valorum Biologics requests your partnership in updating billing systems with the HCPCS code, NDC, and pricing information below.

ARMLUPEG Coding and Pricing Information

HCPCS Code

Q5169

HCPCS Descriptor

Injection, pegfilgrastim-unne (armlupeg), biosimilar, 0.5 mg

Code Effective Date

July 1, 2026

NDC Code*

70748-0273-01

NDC Package Description

Armlupeg PFS 6 mg/0.6 mL Prefilled Syringe, 1 ct

Medicare Payment Limit per HCPCS Unit

$519.481 (effective Oct 1, 2026)

WAC

$508.09 per HCPCS unit
$6,097.08 per package (12 units)

*The above 11-digit NDC code for Valorum Biologics' ARMLUPEG is used for claims processing and reimbursement. The 10-digit NDC code is 70748-273-01.
Medicare payment limit source: CMS ASP Pricing Files, October 2026. View Q5169 pricing on BuyandBill.com.

Billing reminder: Report ARMLUPEG with Q5169 and the 11-digit NDC 70748-0273-01. ARMLUPEG should not be billed using the reference product code, other pegfilgrastim biosimilar codes, or an unclassified drug code. Claims submitted under those codes may be rejected or denied.

Please see ARMLUPEG full Prescribing Information.